Key publication
893
Therapeutic Areas
Methods & challenges

Key publication

Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery-Ã…sberg Depression Rating Scale.

Key publication

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study.

Key publication

A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls.

Key publication

Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.

Key publication

Oral fructose intake does not improve exercise, visual, or cognitive performance during acute normobaric hypoxia in healthy humans.

Key publication

The impact of genotype on phenoconversion by concomitant medication.

Key publication

Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks.

4 July 2023

Movement disorders : official journal of the Movement Disorder Society

Read Publication

Key publication

A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator.

1 July 2023

Movement disorders : official journal of the Movement Disorder Society

Read Publication

Key publication

Current management of uveal melanoma: A review.